This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

—Vladimir Hachinski, MD, FRCPC

Arch Neurol. 1988;45(12):1364.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Magnesium sulfate's reputation waxed as eclampsia's perniciousness waned. Since 1906, when eclampsia was first described, earlier diagnoses, better antihypertensive treatment, and improved intensive care have assured increasingly better results. The omission of control subjects assured that credit would accrue to magnesium sulfate, the treatment of choice. Moreover, because of its wide-spread use, physicians gained extensive experience with use of the drug, decreasing its complications and improving further its apparent beneficial effects. Dinsdale makes a gallant case for the use of magnesium sulfate in eclampsia, based in part on his own considerable knowledge and contributions to the understanding of other types of hypertensive encephalopathy, but he acknowledges that magnesium sulfate's usefulness has never been demonstrated in a controlled clinical trial. Kaplan and colleagues argue convincingly that there are better methods of treating both the hypertension and the seizures commonly associated with eclampsia.

Until such time as we have a better grasp . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?